Our goal is to drive a paradigm shift in diagnosis, understanding and treatment of neurodegenerative diseases.
The foundation of Noselab is a new proprietary ground-breaking diagnostic platform to detect, assess and classify molecular biomarkers through the analysis of nasal secretion.
This unique diagnostic procedure is complemented with an innovative, data-driven medical approach, enabling comprehensive patient profiling, improving the understanding of the disease, as well as supporting personalized treatment decisions.
We are passionate about enabling patients to enjoy more unburdened years in their lives, supporting caregivers and families, while significantly improving global health economics.
Noselab was founded by Dr. Mareike Albert and Thomas Heydler in May 2020 in Munich, Germany. We are an interdisciplinary and experienced team with all necessary aspects to drive our vision forward.
Founder & CSO
Founder & CEO
CFO
COO
CTO
CPO Diagnostics
Scientific Writing
Data Science
Study Coordination
Regulatory Affairs
Team Assistance
Marketing & Operations
Clinical Lab
Product Management
Software Development
Clinical Development
IT Operations
Neuroscience
Our team is complemented by an outstanding advisory team, made of renowned scientific and industrial experts.
Former Director of ENT Department, Ludwig-Maximilians-University Munich
Former Executive at Roche Diagnostics, Ortho Clinical Diagnostics, Tecan Group
Professor of Clinical Neuroanatomy, Head of School of Clinical and Experimental Sciences, University of Southampton
Secretary British Neuropathological Society
Head of Department for Gerontopsychiatry, Central Institute of Mental Health Mannheim (CIMH)
Former Co-CEO of Eppendorf SE, General Manager and Vice President Life Sciences at FEI and Thermo Fisher Scientific, Member Noselab Supervisory Board
Former Scientific Director at Roche Diagnostics
Former Board Member of bioMérieux, Executive at Roche Diagnostics and Chairman of the Noselab Supervisory Board
Head of Memory Clinic, Senior Physician Clinic for Psychiatry and Psychotherapy, Charité Berlin
Co-Founder of mbiomics, Former Chief Strategy and Corporate Development Officer & CFO of Definiens AG, AstraZeneca Group
Head of Clinical Laboratory, Head of Core Unit Analytics and Mass Spectronomy, Max Planck Institute of Psychiatry Munich
Director of Department of Psychiatry and Psychotherapy, University Medical Center Göttingen
We work with strong partners at our side. Discover our network.
You want to participate and engage in something that makes a difference? Join us in uncovering the secret!